Evofem Biosciences, Inc. filed an 8-K report on January 12, 2026, to announce the posting of its current corporate slide presentation on its website, providing updates on its business. This is not deemed as “filed” under the Securities Act or Exchange Act, hence it carries no additional liabilities.